Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom

Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom

Bibliographic Details
Main Authors:	Priyansh Faldu, Kamal Sharma, Shaival Sharma, Smeet Ramani, Nain Dadhania, Ashwati Konat
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	left ventricular assist device (LVAD) heart failure cost-effectiveness destination therapy (DT) HeartWare (HVAD) HeartMate II
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.916588/full

Similar Items

Third‐generation continuous‐flow left ventricular assist devices: a comparative outcome analysis by device type
by: Maks Mihalj, et al.
Published: (2022-10-01)

HeartWare HVAD: Postoperative issues in our first patient
by: Sarvesh Pal Singh, et al.
Published: (2017-01-01)

Use of Intracorporeal Durable LVAD Support in Children Using HVAD or HeartMate 3—A EUROMACS Analysis
by: Martin Schweiger, et al.
Published: (2023-08-01)

Endovascular stenting of an HVAD™ outflow graft pseudoaneurysm that exerts compression and kinking stenosis on the soft portion of the prosthesis
by: Mohamed Elbayomi, et al.
Published: (2023-05-01)

Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
by: Alessandra Francica, et al.
Published: (2023-09-01)

Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
by: Alessandra Francica, et al.
Published: (2023-10-01)

Pericardial release for early LVAD malalignment a less invasive approach
by: Eric I. Jeng, et al.
Published: (2021-03-01)

Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices
by: Maximilian Tscharre, et al.
Published: (2022-02-01)

Totally percutaneous endovascular repair of HeartMate 3 ventricular assistive device outflow graft pseudoaneurysm
by: Mark D. Balceniuk, MD, MPH, et al.
Published: (2020-12-01)

Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
by: Sachin P. Shah, et al.
Published: (2016-04-01)

Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?
by: Chantal C. De Bakker, et al.
Published: (2020-04-01)

What happens when a disruptive technology gets disrupted?
by: Lauren E. Meece, et al.
Published: (2021-06-01)

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
by: Teruhiko Imamura, et al.
Published: (2020-03-01)

Management issues during HeartWare left ventricular assist device implantation and the role of transesophageal echocardiography
by: Sanjay Orathi Patangi, et al.
Published: (2013-01-01)

Chest radiographs of cardiac devices (Part 2): Ventricular assist devices
by: Rishi P. Mathew, et al.
Published: (2019-07-01)

HeartMate 3 biventricular support exceeding 4.5 years
by: Hrvoje Gasparovic, et al.
Published: (2023-06-01)

Eight months of HeartMate II device support without drug therapy
by: Kewal Krishan, et al.
Published: (2017-01-01)

Left Ventricular Assist Device Implantation in a Thrombosed Apical Aneurysm
by: Daniele Masarone, et al.
Published: (2021-07-01)

Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation
by: Mohamed Laimoud, et al.
Published: (2023-12-01)

Biventricular assist devices and total artificial heart: Strategies and outcomes
by: Taiyo Kuroda, et al.
Published: (2023-01-01)

Electrostatic Discharge Causing Pump Shutdown in HeartMate 3
by: Emil Najjar, MD, PhD, et al.
Published: (2021-03-01)

Adverse events with HeartMate-3 Left ventricular assist device: Results from the Manufacturer and User Facility Device Experience (MAUDE) database
by: Joseph N. Heaton, et al.
Published: (2021-11-01)

Ischemic cardiomyopathy is an independent predictor of mortality in patients presenting for Heart Mate II left ventricular assist device implantation
by: Sanjay Kumar, et al.
Published: (2017-01-01)

Left Ventricular Assist Device Implantation in a Patient with Ventricular Pseudoaneurysm
by: Dejan Radakovic, et al.
Published: (2022-01-01)

The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients
by: Marian Urban, et al.
Published: (2016-12-01)

Insights Into the Low Rate of In-Pump Thrombosis With the HeartMate 3: Does the Artificial Pulse Improve Washout?
by: Peng Fang, et al.
Published: (2022-03-01)

Cardiac Assist Devices: Early Concepts, Current Technologies, and Future Innovations
by: Jooli Han, et al.
Published: (2019-02-01)

Comparison of the Hemocompatibility of an Axial and a Centrifugal Left Ventricular Assist Device in an In Vitro Test Circuit
by: Patrick Borchers, et al.
Published: (2022-06-01)

MediGuide-assisted atrial flutter ablation in a patient with a HeartMate II left ventricular assist device
by: Hien Kiem Nguyen Thanh, MD, et al.
Published: (2015-09-01)

The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation
by: Alexandros Briasoulis, et al.
Published: (2020-06-01)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
by: Cecilia Berardi, et al.
Published: (2022-04-01)

Total Joint Arthroplasty in Patients With an Implanted Left Ventricular Assist Device
by: John H. Rosenberg, MD, et al.
Published: (2023-02-01)

Implantable devices: a bridge to heart transplantation
by: D. Zimpfer, et al.
Published: (2019-01-01)

The use of Berlin Heart EXCOR VAD in children less than 10kg: a single center experience
by: Arianna Di Molfetta, et al.
Published: (2016-12-01)

Application of mathematical modeling to quantify ventricular contribution following durable left ventricular assist device support
by: Viswajith S. Vasudevan, et al.
Published: (2022-09-01)

Outcomes of COVID-19 in heart failure, LVAD, and heart transplant patients in an advanced heart failure practice
by: Susan George, et al.
Published: (2022-12-01)

Sex-based considerations for implementation of ventricular assist device therapy
by: K. Candis Jones-Ungerleider, et al.
Published: (2022-10-01)

Combined mechanical circulatory support for ventricular fibrillation in left ventricular assist device patient
by: Mahmood Abu Akel, et al.
Published: (2022-10-01)

Echocardiographic imaging and ventricular mechanics in pulsatile-flow LVAD pediatric patients: a systematic approach
by: R. Iacobelli, et al.
Published: (2024-01-01)

Left Ventricular Assist Device Pump Obstruction Reduces Native Heart Efficiency
by: Ricardo Montes, et al.
Published: (2023-12-01)